SeaStar Medical Holding Corporation (ICU) is a Healthcare stock trading at $3.13 (as of 2026-06-18), with a market capitalization of $6.69M and a trailing P/E of -1.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
SeaStar Medical Holding Corporation is a medical device company developing and commercializing extracorporeal therapies aimed at treating hyperinflammation and cytokine storm in critically ill patients. Its pipeline targets indications such as pediatric and adult acute kidney injury on CRRT, cardiorenal syndrome in congestive heart failure, myocardial stunning in end-stage renal disease, and hepatorenal syndrome.